Brown Cancer Center. Making tomorrow BRIGHTER for everyone.

 

Head and Neck Cancers: Clinical Trials and Research

In addition to using the most advanced methods of diagnosis and treatment, the James Graham Brown Cancer Center participates and initiates a wide range of ongoing clinical trials and research, examining new approaches to treating head and neck cancer. Physicians at the James Graham Brown Cancer Center are among the top researchers in the world and have initiated and participated in many types of clinical research programs. This includes new therapies that may not yet be available in other parts of the region. Our goal is to have new treatment options available for patients at every stage of head and neck cancer. To learn more about available clinical trials, talk to your physician.

Clinical Trials and Research

  • 07.0359 - A Randomized, Open-Label, Controlled, Phase II Trial of Combination Chemotherapy with or without Panitumumab as First-line Treatment of Subject with Metastatic or Recurrent Head and Neck Cancer, and Cross-over Second-line Panitumumab Monotherapy of Subjects who Fail the Combination Chemotherapy Only Arm learn more
  • 07.0010 - A Randomized Phase 3 Study of Pemetrexed in Combination with Cisplatin Versus Cisplatin Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer. learn more
  • 06.0289 - A Phase III Trial of Concurrent Accelerated Radiation and Chemotherapy vs. Concurrent Accelerated Radiation, Chemotherapy, and Cetuximab (C225) for Stage III and IV Head and Neck Carcinomas learn more
  • 07.0333 - Phase II, Single-Arm, Open-Label, Multi-center Trial of Second-line Panitumumab Monotherapy in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck learn more

home | contact | about | send to a friend